Dr. Soliman Abdel Kader Fakeeh Hospital Co. at 35.00, +1.04% today, -2.26% over five days, +1.74% year-to-date. Volume subdued at 1.1x average. The session recorded 1,679 trades at 1.1x normal volume. Price is trading 0.52% above intraday VWAP at 34.82.
Flow indicates divergence: strong buy-side pressure (imbalance 5.47) while smart money is exiting positions. Order flow and smart money signals are misaligned, reflecting mixed participant conviction in current direction. Risk profile is moderate: market-beta (0.91) with moderate volatility. Risk texture shows max drawdown at 15.2% with Sharpe ratio at 3.05.
RSI at 57.1 and Stochastic at 54.4 are aligned. Trend strength is very strong in the sideways direction. Price is contained between support at 34.3 (2.0% below) and resistance at 35.32 (0.9% above). Support sits 2.0% below current price while resistance is 0.9% above. Within the 52-week range (33.02–67.9), price is 48.5% below the high.
The information environment is quiet with no tracked headlines. News mix is neutral: 0 positive vs 0 negative items over 7 days from 0 total tracked. Scale anchor: market cap is 7.9B SAR in the HEALTH_CARE_EQUIPMENT_AND_SVC sector.
Positioning reflects rank 8 of 8 in HEALTH_CARE_EQUIPMENT_AND_SVC, trailing TASI by 5.77% YTD. Against a sector average daily return of 0.73%, the stock's daily return measured 2.12%, an outperformance of 1.39 percentage points. Note: intraday change and daily return measures differ due to calculation basis. Watch which boundary gets tested: 34.3 or 35.32.
Flow:DIVERGENCE
Levels:IN RANGE
Risk:MODERATE
Watch which boundary gets tested: 34.3 or 35.32.
Informational only. Not financial advice.
Price Chart
421 trading days
Since Jun 2024
Technical Analysis
SIDEWAYS
RSI (14)
70.1
Overbought
Volatility (20D)
19.35%
Support
34.49
Resistance
35.33
Moving Averages
SMA 20
34.23
SMA 50
34.79
SMA 200
39.37
MA: Bearish
RSI: Overbought
About Dr. Soliman Abdel Kader Fakeeh Hospital Co.
Dr. Soliman Abdul Kader Fakeeh Company is a prominent player in the healthcare industry of Saudi Arabia. The company specializes in hospital operation services and is renowned for providing comprehensive medical and healthcare facilities, including outpatient centers, clinical laboratories, and pharmaceutical services. Dr. Soliman Abdul Kader Fakeeh Company plays a crucial role in enhancing healthcare accessibility and quality in the region, thus addressing a fundamental societal need. The company is well-regarded for its emphasis on employing cutting-edge medical technologies and hiring highly skilled healthcare professionals to deliver premium services. This company enhances the health and well-being of its clientele by offering specialized medical treatments and preventive care, which are becoming increasingly important in the burgeoning Middle East healthcare sector. With its strategic vision and commitment to excellence, Dr. Soliman Abdul Kader Fakeeh Company holds significant market importance as it contributes to the ongoing development and transformation of regional healthcare services. As a part of the emerging healthcare landscape, it stands out for its innovative approach and dedication to patient-centered care.